Who invested in Amarna Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$11Mraised across 1 round since 2019, from 1 source

Latest round: Round, $11MOct 2019
Investors: 1

See who backed them

The rounds

Oct 2019
Round$11M
- Flerie Invest AB
Reported by FinSMEs

Founders and team

From Amarna Therapeutics's own website: 9 on the team.

Henk StreefkerkChief Executive Officer & Medical Director
Professional ExperienceChief Executive Officer & Medical Director
Tanja MeyerChief Business Officer
Bernhard KirschbaumNon-Executive Director
Maarten de ChâteauNon-Executive Director
Markwin VeldersNon-Executive Director
Pim BergerNon-Executive Director
Sybrand van der WerfSenior Program Director
Thomas ElderedNon-Executive Director & Chairman of the Board

AdvisersBen Samelson JonesColin DayanDesmond SchatzDidac MauricioKei KishimotoLuiza CaramoriProfessor David S. StrayerRoberto Mallone

Everyone who backed them

Flerie Invest ABno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Amarna Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.